Pages that link to "Q30436948"
Jump to navigation
Jump to search
The following pages link to Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort (Q30436948):
Displaying 32 items.
- AMPK: An emerging target for modification of injury-induced pain plasticity (Q27021903) (← links)
- Schwann cell interactions with axons and microvessels in diabetic neuropathy (Q30238727) (← links)
- Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function. (Q30239828) (← links)
- Adenosine Monophosphate-activated Protein Kinase (AMPK) Activators For the Prevention, Treatment and Potential Reversal of Pathological Pain. (Q30383901) (← links)
- Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes (Q34762475) (← links)
- Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. (Q35225448) (← links)
- The influence of autonomic dysfunction associated with aging and type 2 diabetes on daily life activities (Q35903671) (← links)
- Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes (Q35976587) (← links)
- Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (Q36810364) (← links)
- Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort. (Q37193699) (← links)
- The use of metformin is associated with decreased lumbar radiculopathy pain (Q37391076) (← links)
- Peripheral and Autonomic Neuropathy in South Asians and White Caucasians with Type 2 Diabetes Mellitus: Possible Explanations for Epidemiological Differences (Q37734331) (← links)
- Mechanism of diabetic neuropathy: Where are we now and where to go? (Q38213041) (← links)
- Exercise as Therapy for Diabetic and Prediabetic Neuropathy. (Q38625575) (← links)
- Potential of Dietary Non-Provitamin A Carotenoids in the Prevention and Treatment of Diabetic Microvascular Complications (Q38698313) (← links)
- Activity for Diabetic Polyneuropathy (ADAPT): Study Design and Protocol for a 2-Site Randomized Controlled Trial. (Q38841846) (← links)
- Targeting AMPK for the Alleviation of Pathological Pain (Q38998418) (← links)
- Diabetic Neuropathy: A Position Statement by the American Diabetes Association. (Q39044919) (← links)
- Screening and prevalence of peripheral neuropathy in type 2 diabetic outpatients: a randomized multicentre survey in 12 city hospitals of China (Q39943323) (← links)
- Prevalence of diabetic neuropathy in patients undergoing foot and ankle surgery (Q43810053) (← links)
- Alterations in circulating angiogenic and anti-angiogenic factors in type 2 diabetic patients with neuropathy. (Q47862770) (← links)
- Pathophysiological profiles of SDT fatty rats, a potential new diabetic peripheral neuropathy model. (Q47918753) (← links)
- Physical Exercise Improves Heart Rate Variability in Patients with Type 2 Diabetes: A Systematic Review (Q47932887) (← links)
- Effects of metformin on the expression of AMPK and STAT3 in the spinal dorsal horn of rats with neuropathic pain (Q49378684) (← links)
- Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial. (Q53091549) (← links)
- The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. (Q55237417) (← links)
- Community based study to assess the prevalence of diabetic foot syndrome and associated risk factors among people with diabetes mellitus. (Q55462870) (← links)
- Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease (Q57688763) (← links)
- Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study (Q89563228) (← links)
- Neuroprotective Effect of Salvianolic Acid A against Diabetic Peripheral Neuropathy through Modulation of Nrf2 (Q90412423) (← links)
- Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease (Q92771795) (← links)
- Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes (Q92916339) (← links)